elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36407290-091E42BA-3D26-4199-9249-F6FCCF88582E
Q36407290-091E42BA-3D26-4199-9249-F6FCCF88582E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36407290-091E42BA-3D26-4199-9249-F6FCCF88582E
The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome.
P2860
Q36407290-091E42BA-3D26-4199-9249-F6FCCF88582E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36407290-091E42BA-3D26-4199-9249-F6FCCF88582E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
daa4f0aec92cc81b910ba09e739980fe99711fe6
P2860
Emerging treatments for irritable bowel syndrome.